Strong Q1 growth masks execution risks on capex delay
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Achieved revenue/margin guidance implicitly. Missed Odisha timeline (March 2026 target now Q3 FY'27). Bank loan not yet finalized.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivered strong 29% revenue and 68% PAT growth, validating core business. However, management is moderating expectations (targeting ₹30+ Cr quarterly, implying ~10% growth), Odisha capex is delayed 6+ months, and bank loan approval remains pending. Margin sustainability is at risk—only 80-85% of input costs passed through to customers; geopolitical headwinds are acknowledged.
₹27.2 Cr
Revenue · +29.3% YoY₹3.1 Cr
Reported PAT · +68.2% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue grew 29.3% YoY to ₹27.16 Cr
METDelivered result ₹27.2 Cr; transcript reports ₹27.16 Cr; YoY growth matches 29.3%
EBITDA margin sustainable at 15-17% long-term
MISSQ1 EBITDA ₹3.98 Cr yields 14.7% margin; only 80-85% of input costs passed through; West Asia headwinds cited
Odisha epitaxy production by end of Q2 FY'27
MISSPrior guidance: clean room ready mid-March 2026, production 90 days after HT connection (target March 31). Actual: power connected Aug 2026, production now Q3 (6+ month slip)
Targeting ₹30+ Cr quarterly core revenue this year
OVERSTATEDCurrent quarter ₹27.2 Cr; guidance ~10% growth to ₹30+ Cr vs prior 29.3% growth; implies significant slowdown
₹70 Cr bank loan secured for Phase 1 capex
OVERSTATEDIn-principle approval received; final sanction delayed to next week (as of call date Aug 13); not yet disbursed
Earnings quality
What changed since the last call
Odisha timeline slipped 6+ months
DowngradePrior guidance: clean room ready mid-March 2026, production 90 days after HT connection (target March 31, 2026). Actual: transformer energized Aug 13, 2026; epitaxy production now Q3 FY'27.
Core revenue growth moderating to 10%
DowngradeCurrent quarter ₹27.2 Cr with 29.3% YoY growth. Management targeting ₹30+ Cr quarterly going forward, implying ~10% sequential growth vs 29% historical. Cites need for supply-chain optimization, back-end improvements.
Margin sustainability hedged
NeutralQ1 EBITDA margin 14.7%. Management aims for 15-17% but acknowledged only 80-85% cost passthrough in Q1; geopolitical factors create uncertainty. No upgrade from prior 15-17% aspiration; maintained but conditional.
Capex funding status uncertain
Neutral₹70 Cr bank loan application pending final sanction. Government subsidy ₹58 Cr received. Company contribution ₹70 Cr so far. Funding is NOT finalized despite in-principle approval.
The Q&A
Analysts pressed for scale targets, forward commitments, and timelines. Management consistently declined to quantify long-term revenue/PAT targets, citing no forward-looking statements policy. Defensiveness on Odisha delays; CEO acknowledged 6-month slip but repositioned as acceptable given external factors.
Core business scale — Prateek Giri, Subhlabh Research
AnsweredNot yet. Targeting ₹30+ Cr quarterly this year. Will take 6-9 months. Need back-end supply chain work, productivity improvements.
Product portfolio growth — Prateek Giri, Subhlabh Research
AnsweredNeed new products. HPD (high power devices) penetration in India still low; more business from overseas. LPD reached saturation. Growth drivers: HPD India, new equipment products.
R&D investment — Nishita, Sapphire Capital Partners
Answered8%-10% of revenue as long-term policy. Advantage of being agile and innovative in small market.
Margin sustainability — Nishita, Sapphire Capital Partners
PartialDepends on geopolitical factors. Not fully in our control. We aim for 15-17% range.
Cost passthrough — Nishita, Sapphire Capital Partners
AnsweredPassed on 80-85%. Old orders with locked schedules couldn't be renegotiated; all new orders at new prices.
Odisha capex — Nishita, Sapphire Capital Partners
AnsweredPhase 1: ₹225 Cr. Phase 2: ₹395-400 Cr. Total ₹618 Cr. FY'27 spend ₹100-120 Cr Phase 1 only.
Growth strategy and targets — Garvit Goel, Serena Alpha
DodgedGenerally we don't give long-term commitments. Targeting 3-4x growth in top-line and more in bottom-line this year. No specific deadline for ₹X Cr revenue.
Odisha capex split — Prateek Giri, Subhlabh Research
AnsweredGovernment subsidy ₹58 Cr. Company contribution ₹70 Cr (+ ₹8-10 Cr non-CAPEX). Remaining ₹100 Cr being sought via ₹70 Cr bank loan.
Odisha customer readiness — Prateek Giri, Subhlabh Research
PartialApproached international customers in US, Taiwan. Indian govt labs interested. Have specs. Two reactors installed (4, 6, 8-inch). 8-inch for export; 4, 6-inch for India.
Richardson Electronics SiC — Richa, Ample Capital
DodgedFollowing up. No update at this time. Marketing team also following up.
Epi wafer margin — Nishita, Sapphire Capital Partners
AnsweredEpi wafers: 20-25% EBITDA margin. SiC products and devices would be better than epi.
GaN semiconductor roadmap — Charchit Rustagi, Individual Investor
AnsweredFocusing on SiC to full potential first. GaN still has yield issues. Only 100V (charger) and 650V applications viable. SiC likely to capture power side of GaN market in 3 years.
Epi wafer yield targets — Charchit Rustagi, Individual Investor
AnsweredCurrent baseline 85%. Target above 90%. Dicing/curve losses cannot control; focus on defect control.
Guidance
Core business ₹30+ Cr quarterly (vs current ₹27.2 Cr)
MediumImplied ~10% sequential growth. Requires HPD penetration India, equipment division traction. 6-9 months to achieve.
Odisha epitaxy Q3 FY'27 start, ₹12-15 Cr H2 FY'27 revenue
MediumProduction ramp contingent on manufacturing qualification (target 30 days), customer validation. International + Indian govt lab interest noted but no firm orders.
EBITDA margin target 15-17% long-term
LowQ1 achieved 14.7%. 80-85% cost passthrough indicates margin pressure. Geopolitical factors outside control. Sustainability hedged.
Epi wafer EBITDA margin 20-25%
MediumBetter than current 14.7%. Unproven at scale. No yield / manufacturing data yet.
FY'27 capex ₹100-120 Cr (Phase 1 epitaxy)
MediumPhase 2 timing still under discussion. Total Phase 1: ₹225 Cr. Funding: govt subsidy ₹58 Cr + company ₹70 Cr + bank loan ₹70 Cr (pending).
Risks the call surfaced
Capex execution
High₹70 Cr bank loan final sanction pending (as of Aug 13). Odisha Phase 1 capex ₹225 Cr dependent on loan approval. Delays to loan approval would cascade to production timeline (currently Q3 FY'27).
Production ramp
HighOdisha epitaxy production target Q3 FY'27. Qualification and customer validation must complete within 30 days of commissioning. Richardson Electronics 20k SiC chip trial (ongoing since prior call) shows no progress. New customer wins are unproven.
Margin compression
MediumQ1 EBITDA margin 14.7% vs 15-17% target. Only 80-85% of input cost increases passed to customers. West Asia geopolitical headwinds cited. Margin sustainability is hedged by management.
Revenue growth deceleration
MediumCurrent quarter ₹27.2 Cr with 29.3% YoY growth. Management targeting ₹30+ Cr quarterly going forward, implying ~10% sequential growth vs historical 29%. LPD (low power devices) has reached saturation; growth now dependent on HPD India penetration and new products.
Customer concentration / validation risk
MediumRichardson Electronics trial (20k SiC chips) ongoing with no progress update. International customer pipeline early-stage (US, Taiwan approach, no firm orders). Epi wafer customer qualification unproven.
Management
Score 7/10. Transparent on constraints and risks (cost passthrough limits, margin dependencies on external factors). Cautious on forward commitments (explicitly declines multi-year targets). Specific on technical details (optical triggering, SiC roadmap). Evasive on customer trials (Richardson Electronics no update). Mixed track record. Achieved Q1 revenue/margin targets implicitly. Missed Odisha timeline by 6+ months (March 2026 target → Q3 FY'27). Bank loan approval still pending. ₹70 Cr capex raised so far vs ₹225 Cr Phase 1 need indicates slow funding progress.
1 · Sep 2026
Odisha epitaxy production ramp, inauguration event planned
2 · Aug 20, 2026
Bank loan final sanction committee decision (from call date)
3 · Q3 FY'27
Odisha epi wafer revenue generation begins (₹12-15 Cr H2 target)
Margin sustainability is at risk—only 80-85% of input costs passed through to customers; geopolitical headwinds are acknowledged.
Informational and educational content only. Not investment advice.